Designed extension of studies based on conditional power.

PubWeight™: 1.94‹?› | Rank: Top 2%

🔗 View Article (PMID 8589224)

Published in Biometrics on December 01, 1995

Authors

M A Proschan1, S A Hunsberger

Author Affiliations

1: Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892, USA.

Articles citing this

Adaptive design methods in clinical trials - a review. Orphanet J Rare Dis (2008) 2.88

Flexible design for following up positive findings. Am J Hum Genet (2007) 1.94

Personalized medicine using DNA biomarkers: a review. Hum Genet (2012) 1.49

Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment. Biometrika (2011) 1.42

Sample size re-estimation in an on-going NIH-sponsored clinical trial: the secondary prevention of small subcortical strokes experience. Contemp Clin Trials (2012) 1.13

Planning future studies based on the conditional power of a meta-analysis. Stat Med (2012) 1.05

Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look. Stat Med (2011) 1.02

Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency. Trials (2014) 0.93

A comparison of phase II study strategies. Clin Cancer Res (2009) 0.93

Adaptive designs based on the truncated product method. BMC Med Res Methodol (2005) 0.90

Minimizing the maximum expected sample size in two-stage Phase II clinical trials with continuous outcomes. J Biopharm Stat (2012) 0.89

Successful aging: Advancing the science of physical independence in older adults. Ageing Res Rev (2015) 0.86

Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications. Biom J (2014) 0.86

Simultaneous confidence intervals that are compatible with closed testing in adaptive designs. Biometrika (2013) 0.83

A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials. Pharm Stat (2014) 0.82

Unbiased estimation for response adaptive clinical trials. Stat Methods Med Res (2015) 0.82

Adaptive trial designs. Annu Rev Pharmacol Toxicol (2011) 0.81

Adaptive design of confirmatory trials: Advances and challenges. Contemp Clin Trials (2015) 0.81

Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review. J Biopharm Stat (2016) 0.80

Adaptive clinical trial designs in oncology. Chin Clin Oncol (2014) 0.79

Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings. Stat Med (2010) 0.78

Adaptive graph-based multiple testing procedures. Pharm Stat (2014) 0.77

The role of the Data and Safety Monitoring Board in a clinical trial: the CRISIS study. Pediatr Crit Care Med (2013) 0.77

Sample size reassessment for a two-stage design controlling the false discovery rate. Stat Appl Genet Mol Biol (2015) 0.75

Adaptive Multivariate Global Testing. J Am Stat Assoc (2014) 0.75

Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial. Stat Med (2015) 0.75

Precision of maximum likelihood estimation in adaptive designs. Stat Med (2015) 0.75

Longitudinal clinical trials with adaptive choice of follow-up time. Biometrics (2015) 0.75

Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials. PLoS One (2016) 0.75

Changing the Paradigm for the Treatment and Development of New Therapies for FSGS. Front Pediatr (2016) 0.75

Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels. Stat Med (2015) 0.75